Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
PaperCitations, authors & open-access status
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 169 citations, 2020 year and hybrid oa status.
169
Citations
2020
Year
hybrid
OA Status